# US 2012/0253249 A1 · Neuromodulation System and Method For Treating Apnea

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253249 A1
- Document ID: US20120253249A1
- Status: Published application
- Kind: A1
- Application number: 13/108,122
- Filed: 2011-05-16
- Published: 2012-10-04
- Earliest claimed: 2011-03-28
- Assignees: Neurostream Technologies G. P.
- Inventors: Willard Wilson
- Web page: https://patentgrep.com/patent/US20120253249A1

## CPC

- A61N 1/3601: {of respiratory organs}
- A61B 5/389: Electromyography [EMG]
- A61N 1/36057: {adapted for stimulating afferent nerves}
- A61N 1/3611: {Respiration control (stimulating respiratory organs A61N1/3601)}
- A61B 5/02055: {Simultaneously evaluating both cardiovascular condition and temperature}
- A61B 5/0816: {Measuring devices for examining respiratory frequency (measuring frequency of electric signals G01R23/00)}
- A61B 5/087: Measuring breath flow
- A61B 5/113: occurring during breathing
- A61B 5/14542: {for measuring blood gases (A61B5/14551 takes precedence)}
- A61B 5/4818: {Sleep apnoea}
- A61H 9/0007: {Pulsating}
- A61H 9/0021: {Hydraulic massage}
- A61H 21/00: Massage devices for cavities of the body {, e.g. nose, ears and anus (for the genitals A61H19/00); Vibration or percussion related aspects A61H23/00}
- A61H 2205/02: Head
- A61H 2230/206: used as a control parameter for the apparatus
- A61H 2230/208: used as a control parameter for the apparatus
- A61H 2230/255: used as a control parameter for the apparatus
- A61H 2230/405: used as a control parameter for the apparatus
- A61H 2230/605: used as a control parameter for the apparatus
- A61N 1/0548: {Oral electrodes}
- A61N 1/0556: {Cuff electrodes}
- A61N 1/36157: {Current (A61N1/3616 takes precedence)}
- A61N 1/36171: {Frequency}
- A61N 1/36178: {Burst or pulse train parameters}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61H: PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY (electrotherapy, magnetotherapy, radiation therapy or ultrasound therapy A61N)

## Abstract

The present disclosure provides systems and methods for treating apnea by controlled delivery of a swallow stimulus to a subject in which apnea is detected. In the systems and method, burst electrical or mechanical stimulation to one or more swallow-related nerves and/or muscles can be timed for delivery between the expiratory phase of the respiration cycle, following detection of an apneic event in the subject.

## Claims

### Claim 1

A system for treating apnea in a subject, comprising:
a) an electrode configured for positioning in contact with the internal branch of the superior laryngeal nerve (iSLN) of the subject.
b) a control unit comprising:
i. a signal conditioning module for conditioning an electroneurogram signal from the electrode;
ii. an apnea monitoring and detection module operatively coupled to the signal conditioning module and configured for computing an index of respiratory activity from the conditioned electroneurogram signal, wherein when the index of respiratory activity is at or above a predetermined level, the index of respiratory activity is indicative of an occurrence of an apneic event; and
iii. a therapy control module operatively coupled to the apnea monitoring and detection module and configured to control delivery of a swallow stimulus to the subject when the index of respiratory activity is indicative of an occurrence of an apneic event.

### Claim 2 (depends on 1)

The system of claim 1, wherein the swallow stimulus is at least one of: electrical stimulation to at least one swallow-related nerve, electrical stimulation to at least one swallow-related muscle, and mechanical stimulation to at least one swallow-related sensory receptor.

### Claim 3 (depends on 1)

The system of claim 1, wherein the swallow stimulus comprises a burst of electrical stimulation or a burst of mechanical stimulation.

### Claim 4 (depends on 2)

The system of claim 2, wherein the swallow stimulus comprises mechanical stimulation to at least one swallow-related sensory receptor comprising delivery of a liquid to at least one of the oral, nasal, or pharyngeal cavity of the subject.

### Claim 5 (depends on 2)

The system of claim 2, further comprising:
a) a stimulation module operatively connected to the therapy control module; and
b) a stimulation output device coupled to the stimulation module and configured for delivery of the swallow stimulus to the subject, wherein the stimulation module is configured to generate the swallow stimulus through the stimulation output device.

### Claim 6 (depends on 5)

The system of claim 5, wherein the stimulation output device comprises a stimulation electrode coupled to the stimulation module and configured for positioning in contact with at least one swallow-related nerve or muscle, wherein the stimulation module is configured to generate electrical stimulation through the stimulation electrode to at least one swallow-related nerve or muscle.

### Claim 7 (depends on 6)

The system of claim 6, wherein the therapy control module is configured to activate bursts of electrical stimulation to at least one swallow-related nerve or muscle.

### Claim 8 (depends on 5)

The system of claim 5, wherein the stimulation output device comprises a mechanical stimulation delivery device configured to generate mechanical stimulation and deliver the stimulation to at least one swallow-related sensory receptor in the skin or mucosa of the subject.

### Claim 9 (depends on 8)

The system of claim 8, wherein the mechanical stimulation delivery device is configured for delivery of a liquid to the oral, nasal, or pharyngeal cavity of the subject.

### Claim 10 (depends on 9)

The system of claim 9, wherein the therapy control module is configured to activate bursts of mechanical stimulation to the subject.

### Claim 11 (depends on 1, 2, 3)

The system of any of any of claims 1-3, wherein the apnea monitoring and detection module is further configured to detect an apnea.

### Claim 12 (depends on 1, 2, 3)

The system of any of claims 1-3, wherein the index of respiratory activity is indicative of at least one of upper airway pressure, airway stretch, and airway temperature.

### Claim 13 (depends on 12)

The system of claim any of claim 12, wherein the index of respiratory activity is indicative of upper airway pressure.

### Claim 14 (depends on 1, 2, 3)

The system of any of claims 1-3, wherein the index of respiratory activity is further indicative of the respiratory phase in the subject over time, wherein the respiratory phase comprises at least one of an inspiratory phase, an expiratory phase and a zero flow phase.

### Claim 15 (depends on 14)

The system of claim 14, wherein the index of respiratory activity is indicative of respiratory phase, and the therapy control module is further configured to synchronize delivery of burst mechanical stimulation, to at least one swallow-related sensory receptor in the skin or mucosa of the subject between inspiratory phases of the subject, the burst stimulation sufficient to elicit sufficient to elicit all or part of a swallow sequence in the subject.

### Claim 16 (depends on 14)

The system of claim 14, wherein the index of respiratory activity is indicative of respiratory phase, and the therapy control module is further configured to synchronize delivery of burst electrical stimulation, to at least one swallow-related muscle between inspiratory phases of the subject, the burst stimulation sufficient to elicit sufficient to elicit all or part of a swallow sequence in the subject.

### Claim 17 (depends on 14)

The system of claim 14, wherein the index of respiratory activity is indicative of respiratory phase, and the therapy control module is further configured to synchronize delivery of burst electrical stimulation to at least one swallow-related nerve between inspiratory phases, the burst stimulation sufficient to elicit sufficient to elicit all or part of a swallow sequence in the subject.

### Claim 18 (depends on 17)

The system of claim 17, wherein the swallow-related nerve is an afferent nerve or an efferent nerve.

### Claim 19 (depends on 17)

The system of claim 17, wherein the swallow-related nerve is an afferent nerve, wherein stimulation of the afferent nerve triggers swallow reflexive pattern activity in the central nervous system of the subject that is sufficient to elicit all or part of a swallow sequence by the subject.

### Claim 20 (depends on 2)

The system of claim 2, wherein the swallow-related nerve is the superior laryngeal nerve (SLN).

### Claim 21 (depends on 2)

The system of claim 2, wherein the swallow-related nerve the internal branch of the superior laryngeal nerve.

### Claim 22 (depends on 2)

The system of claim 2, wherein the swallow-related nerve is the glossopharyngeal nerve.

### Claim 23 (depends on 2)

The system of claim 2, wherein the swallow-related nerve is the pharyngeal branch of the glossopharyngeal nerve.

### Claim 24 (depends on 2)

The system of claim 2, wherein the swallow-related nerve is an efferent nerve, wherein stimulation of the efferent nerve elicits motor activity in at least one effector of a swallow response in the subject, the motor activity comprising all or part of a swallow sequence by the subject.

### Claim 25 (depends on 3)

The system of claim 3, wherein the apnea monitoring and detection module is further configured to compare the index of respiratory activity following delivery of each burst of stimulation, to a predetermined recovery threshold and thereby detect recovery from apnea in response to each burst of stimulation.

### Claim 26 (depends on 25)

The system of claim 25, wherein the therapy control module is further configured to repeat delivery of burst stimulation when recovery from apnea is not detected.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The system of any of claims 1-10, wherein the system is partially or fully implantable.

### Claim 28

A method for treating apnea, the method comprising:
a) sensing a respiratory signal in a subject;
b) detecting apnea based on the respiratory signal;
c) when apnea is detected, triggering the delivery of a swallow stimulus sufficient to elicit all or part of a swallow in the subject; and
d) optionally repeating steps (a) through (c).

### Claim 29 (depends on 28)

The method of claim 28, wherein the swallow stimulus comprises at least one of: electrical stimulation to at least one swallow-related nerve, electrical stimulation to at least one swallow-related muscle, and mechanical stimulation to at least one swallow-related sensory receptor in the skin or mucosa of the subject, the swallow stimulus sufficient to elicit all or part of a swallow sequence in the subject.

### Claim 30 (depends on 29)

The method of claim 29, wherein the swallow stimulus comprises burst electrical stimulation or burst mechanical stimulation.

### Claim 31 (depends on 29)

The method of claim 29, wherein the swallow stimulus comprises mechanical stimulation to at least one swallow-related sensory receptor, comprising delivery of a liquid to at least one of the oral, nasal, or pharyngeal cavity of the subject.

### Claim 32 (depends on 29)

The method of claim 29, wherein the swallow stimulus comprises electrical stimulation to at least one swallow-related nerve or muscle.

### Claim 33 (depends on 30)

The method of claim 30, wherein the respiratory signal further comprises a signal indicative of respiratory phase in the subject over time, wherein the respiratory phase comprises at least one of an inspiratory phase, an expiratory phase and a zero flow phase.

### Claim 34 (depends on 33)

The method of claim 33, wherein the triggering of the electrical burst stimulation or mechanical burst stimulation comprises synchronizing the delivery of the burst stimulation between inspiratory phases of the subject.

### Claim 35 (depends on 28)

The method of claim 28, further comprising computing an index of respiratory activity indicative of at least one of upper airway pressure, airway stretch, and airway temperature.

### Claim 36 (depends on 35)

The method of claim 35, wherein the index of respiratory activity is indicative of upper airway pressure.

### Claim 37

A method for treating sleep apnea, the method comprising:
a) recording an electroneurogram signal from the internal branch of the superior laryngeal nerve (iSLN) of the subject;
b) conditioning the electroneurogram signal;
c) computing an index of respiratory activity from the conditioned electroneurogram signal;
d) reporting an occurrence of an apneic event when the index of respiratory activity is at or above a predetermined level; and
e) upon occurrence of an apneic event, triggering delivery of a swallow stimulus to the subject, wherein the swallow stimulus is sufficient to elicit all or part of a swallow sequence in the subject.

### Claim 38 (depends on 37)

The method of claim 37, wherein the swallow stimulus comprises at least one of: electrical stimulation to at least one swallow-related nerve, electrical stimulation to at least one swallow-related muscle, and mechanical stimulation to at least one swallow-related sensory receptor in the skin or mucosa of the subject.

### Claim 39 (depends on 38)

The method of claim 38, wherein the swallow stimulus comprises burst electrical stimulation or burst mechanical stimulation.

### Claim 40 (depends on 38)

The method of claim 38, wherein the swallow stimulus comprises mechanical stimulation to at least one swallow-related sensory receptor, comprising delivery of a liquid to at least one of the oral, nasal, or pharyngeal cavity of the subject.

### Claim 41 (depends on 38)

The method of claim 38, wherein the swallow stimulus comprises electrical stimulation to at least one swallow-related swallow-related nerve or muscle.

### Claim 42 (depends on 41)

The method of claim 41, comprising electrical stimulation to at least two swallow-related nerves, at least two swallow-related muscles, or at least a swallow-related nerve and a swallow-related muscle.

### Claim 43 (depends on 39)

The method of claim 39, wherein the respiratory signal further comprises a signal indicative of respiratory phase in the subject over time, wherein the respiratory phase comprises at least one of an inspiratory phase, an expiratory phase and a zero flow phase.

### Claim 44 (depends on 43)

The method of claim 43, wherein the respiratory signal is indicative of respiratory phase in the subject over time, and the triggering of the electrical burst stimulation or mechanical burst stimulation comprises synchronizing the delivery of the burst stimulation between inspiratory phases of the subject.

### Claim 45 (depends on 39)

The method of claim 39, wherein the index of respiratory activity is indicative of at least one of upper airway pressure, airway stretch, and airway temperature.

### Claim 46 (depends on 45)

The method of claim 45, wherein the index of respiratory activity is indicative of upper airway pressure.

### Claim 47 (depends on 43)

The method of claim 43, wherein the swallow stimulus comprises burst electrical stimulation to at least one swallow-related nerve wherein a swallow-related nerve is an afferent nerve or an efferent nerve.

### Claim 48 (depends on 47)

The method of claim 47, comprising burst electrical stimulation to at least two swallow-related nerves wherein each swallow-related nerve is independently an afferent nerve or an efferent nerve.

### Claim 49 (depends on 41)

The method of claim 41, wherein the swallow-related nerve is an afferent nerve, wherein stimulation of the afferent nerve elicits swallow reflexive pattern activity from the central nervous system of the subject sufficient to elicit all or part of a swallow sequence in the subject.

### Claim 50 (depends on 38)

The method of claim 38, wherein the swallow-related nerve is the internal branch of the superior laryngeal nerve (iSLN).

### Claim 51 (depends on 38)

The method of claim 38, wherein the swallow-related nerve is the pharyngeal branch of the glossopharyngeal nerve.

### Claim 52 (depends on 38)

The method of claim 38, wherein the swallow-related nerve is an efferent nerve, wherein stimulation of the efferent nerve elicits motor activity in at least one effector in a swallow sequence, the motor activity comprising all or part of a swallow sequence in the subject.

### Claim 53 (depends on 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)

The method of any of claims 39-52, further comprising comparing the electroneurogram signal following delivery of each burst of stimulation, to a predetermined recovery threshold and thereby detecting recovery from apnea in response to each burst of stimulation.

### Claim 54 (depends on 53)

The method of claim 53, further comprising repeating a burst of stimulation when recovery from apnea is not detected.

### Claim 55 (depends on 39, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The method of any of claims 39 and 41-53, wherein delivering electrical stimulation comprises delivering a burst of stimulus pulses having a frequency of at least about 20 Hz to about 40 Hz, wherein each pulse has an amplitude of greater than about 0.1 mA and a duration of about 200 μsec.

### Claim 56

A device for treating apnea in a subject, comprising:
a) an electrode configured for positioning in contact with the internal branch of the superior laryngeal nerve (iSLN) of the subject, further configured for obtaining an electroneurogram signal from the iSLN and for delivering electrical stimulation to the iSLN;
b) a control unit comprising:
i. a signal conditioning module for conditioning the electroneurogram signal from the electrode; and
ii. an apnea monitoring and detection module operatively coupled to the signal conditioning module and configured for computing an index of respiratory activity from the conditioned electroneurogram signal, wherein when the index of respiratory activity is at or above a predetermined level, the index of respiratory activity is indicative of an occurrence of an apneic event;
iii. a therapy control module wherein the therapy control module is configured to control delivery of a swallow stimulus, wherein delivery of the swallow stimulus is triggered when the index of respiratory activity is indicative of an occurrence of an apneic event.

### Claim 57 (depends on 56)

The device of claim 56, wherein the therapy control module is configured to control delivery of electrical stimulation through the electrode to at least one swallow-related nerve when the index of respiratory activity is indicative of an occurrence of an apneic event.

### Claim 58 (depends on 56)

The device of claim 56, wherein the control unit? comprises a respiratory phase module configured to determine respiratory phase from the index of respiratory activity and to generate a respiratory phase signal from the subject.

### Claim 59 (depends on 58)

The device of claim 58, wherein the therapy control module is further configured to activate burst stimulation of the iSLN between inspiratory phases based on the respiratory phase signal, the burst stimulation sufficient to produce all or part of a swallow sequence in the subject.

### Claim 60 (depends on 59)

The device of claim 59, wherein the electrode and therapy control module are implantable.

### Claim 61 (depends on 56)

The device of claim 56 further comprising a stimulus output device configured for oral, nasal or pharyngeal delivery of a liquid to the subject and operatively coupled to the therapy control module, wherein the therapy control module is further configured to activate oral, nasal or pharyngeal delivery of liquid to the subject when the index of respiratory activity is indicative of an occurrence of an apneic event.

### Claim 62

A method for treating dysphagia, the method comprising:
a) sensing a dysphagia signal in a subject;
b) detecting dysphagia based on the dysphagia signal;
c) when dysphagia is detected, triggering the delivery of a swallow stimulus sufficient to elicit all or part of a swallow in the subject; and
d) optionally repeating steps (a)-(c).

### Claim 63 (depends on 62)

The method of claim 62, wherein the swallow stimulus comprises at least one of: electrical stimulation to at least one swallow-related nerve, electrical stimulation to at least one swallow-related muscle, and mechanical stimulation to at least one swallow-related sensory receptor in the skin or mucosa of the subject.

### Claim 64 (depends on 62)

The method of claim 62, wherein the swallow stimulus comprises burst electrical stimulation or burst mechanical stimulation.

### Claim 65 (depends on 62)

The method of claim 62, further comprising sensing a respiratory signal, wherein the respiratory signal is indicative of respiratory phase, wherein the respiratory phase is either an inspiratory phase, an expiratory phase, or a zero flow phase and the triggering of the burst stimulation comprises synchronizing the delivery of the burst stimulation between inspiratory phases of the subject.

### Claim 66 (depends on 62)

The method of claim 62, wherein the swallow stimulus comprises mechanical stimulation to at least one swallow-related sensory receptor, comprising delivery of a liquid to at least one of the oral, nasal, or pharyngeal cavity of the subject.

### Claim 67 (depends on 62)

The method of claim 62, wherein the swallow stimulus comprises electrical stimulation to at least one swallow-related nerve or muscle.
